6h
Zacks Investment Research on MSNCVS Health Takes the Lead in 2025 S&P 500 Chart: Is It a Buy Now?In a year marked by macroeconomic uncertainty and renewed trade tensions that have shaken the equity market, CVS Health CVS has emerged as an unexpected outperformer. After a rough 2024, marked by ...
CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...
A woman says a popular CVS supplement caused her to be sent to the hospital with organ failure. Here's what you need to know.
Shares of CVS Health climbed 6.5%, to $68, in after-hours trading, while shares of UnitedHealth Group rose 6%, to $556. Spire Global reached an agreement with Kpler regarding a disputed deal for the ...
One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% ...
In a motion to dismiss most claims, attorneys for the Woonsocket, R.I.-based company argue the DOJ failed to provide key ...
Store closure decisions are based on several factors,” including population shifts and consumer buying patterns, a company ...
CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...
CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...
The healthcare sector, as measured by Health Care Select Sector SPDR Fund (NYSEARCA:XLV), with 12.12% weightage on the S&P ...
The company announced Monday that the MMR vaccine would be available at more than 500 locations of CVS Pharmacy stores and ...
Shares of CVS Health Corp. CVS slipped 1.61% to $66.48 Tuesday, on what proved to be an all-around positive trading session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results